Honda Prize 2024 Awarded to Dr. James G. Fujimoto of U.S.

September 30, 2024 05:00 PM AEST | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

- For Contributing to Invention and Development of Optical Coherence Tomography -

TOKYO, Sept. 30, 2024 /PRNewswire/ -- The Honda Foundation is a public interest incorporated foundation established by Soichiro Honda and his younger brother Benjiro, and is currently led by President Hiroto Ishida. The foundation established the Honda Prize in 1980 as Japan's first international award that acknowledges achievements contributing to "the creation of a truly humane civilization."

In 2024, the 45th Honda Prize will be awarded to Dr. James G. Fujimoto, Elihu Thomson Professor of Electrical Engineering at the Research Laboratory of Electronics, Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology (MIT), the U.S.A., for his research group's development of optical coherence tomography (OCT). The prize also acknowledges his contribution to the commercialization and clinical translation of OCT in ophthalmology, cardiology, and biomedical research.

Image1: https://cdn.kyodonewsprwire.jp/prwfile/release/M106338/202409267062/_prw_PI1fl_1vE8ITa5.jpg

OCT is a new imaging modality which is analogous to ultrasound, except that it measures the echo time delay and magnitude of backscattered light instead of sound. OCT enables real-time, microscopic resolution imaging of a subsurface structure in biological tissues and materials. It has applications in multiple medical specialties as well as fundamental research and manufacturing. OCT can be combined with fiber optic catheters, endoscopes, and laparoscopes to enable imaging inside the body. It enables "optical biopsy," imaging pathology in real time, without the need to remove specimens as in conventional excisional biopsy.

The development of OCT is an example of the power of multidisciplinary collaborative research teams which span fundamental research, engineering, clinical medicine, and industry. In the late 1980s, such a multidisciplinary project was relatively uncommon, and Dr. Fujimoto's team demonstrated a pioneering approach to joint medical-engineering research.

Dr. Fujimoto's team first aimed to apply OCT in ophthalmology. OCT was invented by David Huang, an MD, PhD student in Fujimoto's research group, working in close collaboration with Eric Swanson, an expert on satellite optical communication, and Drs. Carmen Puliafito and Joel Schuman, retina and glaucoma specialists. OCT has become a standard of care in ophthalmology with 20 to 30 million procedures performed worldwide every year. It facilitates early detection of diseases such as age-related macular degeneration, diabetic retinopathy, and glaucoma, enabling patients to be treated before irreversible loss of vision occurs.

Intravascular OCT was pioneered by visiting scientist Mark Brezinski, an MD, PhD cardiologist. Startup companies led by Swanson combined with industry investment played a key role in commercializing OCT in ophthalmology as well as cardiology. Today there is an international research community with over 100 academic research groups and companies developing OCT technology and clinical applications.

Image2: https://cdn.kyodonewsprwire.jp/prwfile/release/M106338/202409267062/_prw_PI2fl_2xyDX5ml.jpg

OCT can be used to guide disease treatment, improving outcomes and saving health care costs. In the future, OCT of the eye may be used in optometrists' shops, drug stores, and primary care doctors' offices to screen for diabetes, neurological and other systemic diseases. In the field of cardiology, intravascular OCT is emerging as a valuable technique for guiding treatment of myocardial infarction. Clinical studies have shown intravascular OCT treatment guidance can reduce rates of major adverse cardiac events.

Over the years, the Honda Foundation has been promoting "ecotechnology*" as its mission. Dr. Fujimoto, who led the OCT research team, is the only researcher who consistently contributed to the development and the dissemination of OCT is fully in accord with the mission and worthy of the highest recognition. Therefore, the 45th Honda Prize will be awarded to Dr. Fujimoto.

An award ceremony will be held at the Imperial Hotel in Tokyo, Japan, on November 18, 2024. In addition to a prize medal and a diploma, the laureate will be awarded 10 million yen.

*Ecotechnology: Human-friendly philosophy founded on science and technology. It is designed to harmonize the natural and human environments, and find resolutions to social issues, adopting a methodology that implies something more than just "being friendly to the Earth," which is the meaning usually associated with the word "ecology."

For more information, please visit: https://kyodonewsprwire.jp/attach/202409267062-O1-zZ1Tz5H4.pdf

Official website: https://www.hondafoundation.jp/en/


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Two ASX Listed Stocks Giving Bullish Indications

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.